PEACCEL at glance
April 13th, 2026
Making the world
disease free
We find the real drug
lead candidate by
capturing the synergistic effect of
mutations (epistasis)
We have developed the
innov’SAR AI platform
for our partners.
What makes PEACCEL different is that it can produce massive amounts of synthetic data to train its ML/DL platform. Other companies have taken the shortcut of relying on existing datasets which are often messy and of low quality.
The innov’SAR core approach is interpolative, extrapolative and predicts out-of-the-box, not found in other state-of-the-art ML / DL. It can screen 1 Billion mutants per day.
PEACCEL is definitely the only company capable of fully capturing epistasis and predicting outside-the-box, we are ahead of competition especially in terms of “hit rate”.
The innov’SAR core approach is interpolative, extrapolative and predicts out-of-the-box, not found in other state-of-the-art ML / DL. It can screen 1 Billion mutants per day.
PEACCEL is definitely the only company capable of fully capturing epistasis and predicting outside-the-box, we are ahead of competition especially in terms of “hit rate”.
PEACCEL's world-class
Data Scientists in Life Sciences
History
2024
Awarded DeepTech Label by BPI France
Quantum Computing for Biologics
2021-2023
Patent on proprietary molecules
AI Platform for Biologics 3.0
Technology Patents Worldwide
Awards Winner in Artificial Intelligence for Life Sciences
2019-2020
Contracts with key players in chemical industry
innov'SAR integrated platform for Protein Engineering & Fixed Drugs Combinations (FDCs)
€2m competitive EU funds
First contracts with key pharmaceuticals companies
Industrial Fields:
Artificial Intelligence, Machine Learning, Deep Learning, Quantum Computing, Biotechnology, Pharmaceuticals, Chemistry
Artificial Intelligence, Machine Learning, Deep Learning, Quantum Computing, Biotechnology, Pharmaceuticals, Chemistry
PEACCEL is built around the 6 pillars - P6 - :
Platform | Publications | Patents | Partnership | Products | People
We have developped the "innov'SAR" PLAFTORM, including 4 modules :
innov'SAR core
RAS module
AutomISAR
GraphMut
innov'SAR core RAS module AutomISAR GraphMut
15 PUBLICATIONS in peer reviewed journals in less than 2 years
Strong worldwide PATENTS on technology using FFT, with more to come
Robust PARTNERSHIPS with top notch KOLs worldwide
Focus on high value PRODUCTS
Highly skilled PEOPLE in high tech fields
PEACCEL is managed by a seasoned multinational team accumulating scientific, business and management experienced in chemical, pharmaceutical and biotech industry.
The company operates in Paris (France) and Cambridge (MA, USA).
The company operates in Paris (France) and Cambridge (MA, USA).
